zanamivir has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, O; Gkioule, C; Grund, S; Kobbe, G; Pfeifer, N; Termos, T; Verheyen, J | 1 |
| Carrington, D; Clark, A; Johny, AA; Marks, DI; Oakhill, A; Price, N | 1 |
1 trial(s) available for zanamivir and Myelodysplastic Syndromes
| Article | Year |
|---|---|
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Female; Guanidines; Hematologic Neoplasms; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Myelodysplastic Syndromes; Pyrans; Sialic Acids; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Zanamivir | 2002 |
1 other study(ies) available for zanamivir and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions.
Topics: Amino Acid Substitution; Antiviral Agents; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Mutation; Myelodysplastic Syndromes; Neuraminidase; Oseltamivir; Viral Proteins; Zanamivir | 2015 |